Leo Luznik

12.2k citations

129 papers · 5.6k indexed · 1 hit paper · h-index 41

Impact in

Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments

Papers in

Hematology 110
- Hematopoietic Stem Cell Transplantation 100
- Acute Myeloid Leukemia Research 22
Transplantation 18
- Renal Transplantation Outcomes and Treatments 17

Co-authors: Ephraim J. Fuchs Richard J. Jones Paul V. O’Donnell Christopher G. Kanakry Javier Bolaños‐Meade Robert A. Brodsky Richard F. Ambinder Mary S. Leffell
Journals: Biology of Blood and Marrow Transplantation (43 papers)Blood (40 papers)Bone Marrow Transplantation (5 papers)Blood Advances (4 papers)Seminars in Hematology (3 papers)
Partner nations: United States Austria Italy

In The Last Decade

Leo Luznik

127 papers receiving 5.5k citations

Hit Papers

align trajectories log scale

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease 2016 · 283 citations

Peers

Countries citing papers authored by Leo Luznik

Since Specialization

Citations

This map shows the geographic impact of Leo Luznik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Luznik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Luznik more than expected).

Fields of papers citing papers by Leo Luznik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Luznik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Luznik. The network helps show where Leo Luznik may publish in the future.

Co-authors

The 25 scholars most cited alongside Leo Luznik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leo Luznik Line = papers co-authored together Leo Luznik links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD Blood ·Saurav Shil, Lars H. Wendt, Cameron McDonald-Hyman, Christina R. Hartigan, Peter T. Sage, Keli L. Hippen, Brent H. Koehn, Angela Panoskaltsis‐Mortari, Megan Riddle, Cindy Eide, Jakub Tolar, Geoffrey R. Hill, Leo Luznik, Corey Cutler, Jerome Ritz, Leslie S. Kean, Ageliki Tsagaratou, Anjana Rao, Bruce R. Blazar	2025	1
2	Relapse after allogeneic transplantation with post-transplant cyclophosphamide: Shattering myths and evolving insight Blood Reviews ·Shannon R. McCurdy, Leo Luznik	2023	6
3	Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source Transplantation and Cellular Therapy ·mohamad ali Haddadian, 傅学斌, Hua‐Ling Tsai, 征一郎大西, Ephraim J. Fuchs, Lode J. Swinnen, Suman Paul, Javier Bolaños‐Meade, Leo Luznik, Philip Imus, Syed Abbas Ali, Tania Jain, Alexander J. Ambinder, Amy E. DeZern, Carol Ann Huff, Christian B. Gocke, Ravi Varadhan, Nina D. Wagner‐Johnston, Richard J. Jones, Richard F. Ambinder	2022	6
4	BMT CTN 1803: Haploidentical Natural Killer Cells (K-NK002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM) Transplantation and Cellular Therapy ·Sumithira Vasu, Nelli Bejanyan, Steven M. Devine, Elizabeth O. Hexner, Brent R. Logan, Leo Luznik, Brittany Knick Ragon, Lianjun Guo, Elizabeth F. Krakow, Michael Fitzgerald, Lorraine Tracey, Richard E. Champlin	2021	2
5	Bone Marrow GZMK +IL7R + Progenitor-Exhausted CD8 + T Cells Correlate with Sustained Clinical Remission in Patients with Acute Myeloid Leukemia (AML) Undergoing Chemotherapy Blood ·Francesco Mazziotta, 正孫福, Rupkatha Mukhopadhyay, Hanna A. Knaus, Ivan Borrello, Ivana Gojo, Leo Luznik	2021	0
6	Treatment of AML Relapse After Allo-HCT Frontiers in Oncology ·Jonathan Webster, Leo Luznik, Ivana Gojo	2021	19
7	HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis Blood Advances ·Mohamad Aghaie Meybodi, Wenhao Cao, Leo Luznik, Asad Bashey, Xu Zhang, Rizwan Romee, Wael Saber, Mehdi Hamadani, Daniel J. Weisdorf, Haitao Chu, Armin Rashidi	2019	28
8	Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Philip Imus, Amanda L. Blackford, Maria Bettinotti, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Richard F. Ambinder, Ivan Borrello, Butler III, Lode J. Swinnen, Nina D. Wagner‐Johnston, Christian B. Gocke, Syed Abbas Ali, Civale Leonardo, Richard J. Jones, Amy E. DeZern	2019	56
9	A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure Clinical Cancer Research ·Amer M. Zeidan, Hanna A. Knaus, Tara M. Robinson, Andrea Towlerton, Edus H. Warren, Joshua F. Zeidner, Amanda L. Blackford, Amy S. Duffield, David A. Rizzieri, Mark G. Frattini, Yair Levy, Mark A. Schroeder, Anna Ferguson, Francoise Maxime, Amy E. DeZern, Ivana Gojo, Steven D. Gore, Howard Streicher, Leo Luznik, B. Douglas Smith	2018	74
10	Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma Biology of Blood and Marrow Transplantation ·Nilanjan Ghosh, Xiaobu Ye, Hua-Ling Tsai, Javier Bolaños‐Meade, Ephraim J. Fuchs, Leo Luznik, Lode J. Swinnen, Douglas E. Gladstone, Richard F. Ambinder, Ravi Varadhan, Satish Shanbhag, Robert A. Brodsky, Ivan Borrello, Richard J. Jones, William Matsui, Carol Ann Huff	2017	12
11	Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium—Haplo2014, San Francisco, California, December 4, 2014 Biology of Blood and Marrow Transplantation ·Monzr M. Al Malki, Mary M. Horowitz, Rupert Handgretinger, Wing Leung, Denis-Claude Roy, Xiao‐Jun Huang, Ephraim J. Fuchs, Franco Locatelli, Didier Blaise, Shin Mineishi, Maria Paola Martelli, Jeffrey S. Miller, Carl H. June, S Drakulic, Leo Luznik, Domenico Mavilio, Enrico Lugli, Marcel R.M. van den Brink, Richard E. Champlin, Stefan O. Ciurea	2016	7
12	The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease Biology of Blood and Marrow Transplantation ·Kenneth R. Cooke, Leo Luznik, Stefanie Sarantopoulos, Frances T. Hakim, Madan Jagasia, Daniel H. Fowler, Marcel R.M. van den Brink, John A. Hansen, Robertson Parkman, David B. Miklos, Paul J. Martin, Sophie Paczesny, Georgia B. Vogelsang, Steven Z. Pavletic, Jerome Ritz, Kirk R. Schultz, Bruce R. Blazar Hit paper breakdown →	2016	283
13	Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors Biology of Blood and Marrow Transplantation ·Jennifer A. Kanakry, Christopher D. Gocke, Javier Bolaños‐Meade, Douglas E. Gladstone, Lode J. Swinnen, Amanda L. Blackford, Ephraim J. Fuchs, Carol Ann Huff, Ivan Borrello, William Matsui, Robert A. Brodsky, Gary L. Rosner, Satish Shanbhag, Leo Luznik, Richard J. Jones, Richard F. Ambinder, Yvette L. Kasamon	2015	16
14	HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease Blood ·Javier Bolaños‐Meade, Ephraim J. Fuchs, Leo Luznik, Sophie Lanzkron, Christopher Gamper, Richard J. Jones, Robert A. Brodsky	2012	306
15	High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas Leukemia & lymphoma ·Douglas E. Gladstone, Javier Bolaños‐Meade, Carol Ann Huff, Marianna Zahurak, Ian W. Flinn, Ivan Borrello, Leo Luznik, Ephraim J. Fuchs, Yvette L. Kasamon, William Matsui, Jonathan D. Powell, Hyam I. Levitsky, Robert A. Brodsky, Richard F. Ambinder, Richard J. Jones, Lode J. Swinnen	2011	4
16	STAT3 Signaling in CD4+ T Cells Is Critical for the Pathogenesis of Chronic Sclerodermatous Graft-Versus-Host Disease in a Murine Model The Journal of Immunology ·Vedran Radojčić, Maria Pletneva, Hung‐Rong Yen, Sanja Ivčević, Angela Panoskaltsis‐Mortari, Anita C. Gilliam, Charles G. Drake, Bruce R. Blazar, Leo Luznik	2009	65
17	Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma Annals of Oncology ·Yvette L. Kasamon, Richard J. Jones, Robert A. Brodsky, Ephraim J. Fuchs, William Matsui, Leo Luznik, Jonathan D. Powell, Amanda L. Blackford, Amy Goodrich, Haiyan Liao, Ross A. Abrams, Richard F. Ambinder, Ian W. Flinn	2009	11
18	Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen Bone Marrow Transplantation ·Javier Bolaños‐Meade, Leo Luznik, Dyisheng Lin, William Matsui, Carol Ann Huff, B. Douglas Smith, Moshe Levy, Yvette L. Kasamon, L. J. Swinnen, Jonathan D. Powell, Robert A. Brodsky, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs	2008	10
19	Host-Derived Langerhans Cells Persist after MHC-Matched Allografting Independent of Donor T Cells and Critically Influence the Alloresponses Mediated by Donor Lymphocyte Infusions The Journal of Immunology ·Nadira Duraković, 毅矢追, Mario Škarica, Vedran Radojčić, Ephraim J. Fuchs, Gëorge F. Murphy, Leo Luznik	2006	30
20	Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation Biology of Blood and Marrow Transplantation ·Leo Luznik, Laura Engstrom, Robert Iannone, Ephraim J. Fuchs	2002	86

About Leo Luznik

Leo Luznik is a scholar working on Hematology, Transplantation, Immunology, Oncology and Genetics, having authored 129 papers that have together received 5.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (100 papers), Immune Cell Function and Interaction (47 papers), T-cell and B-cell Immunology (37 papers), Acute Myeloid Leukemia Research (22 papers), Acute Lymphoblastic Leukemia research (20 papers), Polyomavirus and related diseases (19 papers), Renal Transplantation Outcomes and Treatments (17 papers) and CAR-T cell therapy research (14 papers). The work is most often cited by research in Hematology (4.4k citations), Transplantation (525 citations), Immunology (2.8k citations), Genetics (858 citations) and Oncology (1.6k citations). Leo Luznik has collaborated with scholars based in United States, Austria and Italy. Frequent co-authors include Ephraim J. Fuchs, Richard J. Jones, Paul V. O’Donnell, Christopher G. Kanakry, Javier Bolaños‐Meade, Robert A. Brodsky, Richard F. Ambinder, Mary S. Leffell, Bruce R. Blazar and Shannon R. McCurdy. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Blood, Bone Marrow Transplantation, Blood Advances and Seminars in Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact